Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Hayley Pye, Mohammed Adil Butt, Laura Funnell, Halla W. Reinert, Ignazio Puccio, Saif U. Rehman Khan, Savvas Saouros, Jared S. Marklew, Ioanna Stamati, Maryam Qurashi, Rehan Haidry, Vinay Sehgal, Dahmane Oukrif, Michael Gandy, Hayley C. Whitaker, Manuel Rodriguez-Justo, Marco Novelli, Rifat Hamoudi, Gokhan Yahioglu, Mahendra P. Deonarain, Laurence B. Lovat
Published May 1, 2018 · Vol. 9, No. 33 · pp. 22945-22959
Diana Horvath-Rizea, Alexey Surov, Karl-Titus Hoffmann, Nikita Garnov, Cathrin Vörkel, Patricia Kohlhof-Meinecke, Oliver Ganslandt, Hansjörg Bäzner, Georg Alexander Gihr, Marcell Kalman, Elina Henkes, Hans Henkes, Stefan Schob
Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18148-18159
Matthias Felix Haefner, Frederik Lars Giesel, Matthias Mattke, Daniel Rath, Moritz Wade, Jacob Kuypers, Alan Preuss, Hans-Ulrich Kauczor, Jens-Peter Schenk, Juergen Debus, Florian Sterzing, Roland Unterhinninghofen
Published Jan 8, 2018 · Vol. 9, No. 5 · pp. 6490-6498
